Strata Critical Medical Inc (SRTA) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Strata Critical Medical Inc   (NASDAQ: SRTA)


Strata Critical Medical Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SRTA Gross Profit Margin (Sep 30 2026)
Q3 		(Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3
Y / Y Revenue Change 50.27 %
Seq. Revenue Change 2.17 %
Revenue In Millions $74.08
Gross Profit Margin 22.7 %
Gross Profit Margin Total Ranking # 2878
Gross Profit In Millions $16.82
Y / Y Gross Profit Change 44.83 %
Seq. Gross Profit Change 10.55 %


Commenting Third Quarter 2026 Gross Profit Margin
Strata Critical Medical Inc Gross Profit grew by 10.55 % in Q3 sequentially to 17 millions, while Revenue increased by 2.17 %, this led to improvement in the company's Gross Profit Margin to 22.7 %, above the Strata Critical Medical Inc average Gross Profit Margin.


Observing third quarter 2026 results within Medical Equipment & Supplies industry 162 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 2878.
Learn about Gross Margin
SRTA's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 412
Overall # 2854

Gross Profit Margin Statistics
High Average Low
26.49 % 20.21 % 10.98 %
(Sep 30 2024)   (Mar 31 2022)


SRTA Gross Income Trends • More of SRTA's Profitabilty Ratios • SRTA Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
SRTA's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SRTA's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SRTA's Competitors
Gross Profit Margin Profit Margin for Strata Critical Medical Inc 's Suppliers
Gross Profit Margin Profit Margin for SRTA's Customers

You may also want to know
SRTA's Annual Growth Rates SRTA's Profitability Ratios SRTA's Asset Turnover Ratio SRTA's Dividend Growth
SRTA's Roe SRTA's Valuation Ratios SRTA's Financial Strength Ratios SRTA's Gross Profit Growth
SRTA's Roa SRTA's Inventory Turnover Ratio SRTA's Growth Rates SRTA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginSep 30 2026 MRQ Gross ProfitSep 30 2026 MRQ Revenue
Sintx Technologies Inc   62.19 %$ 1.362  Millions$ 2.190  Millions
Haemonetics Corporation  61.75 %$ 220.913  Millions$ 357.759  Millions
Anika Therapeutics Inc   61.57 %$ 18.837  Millions$ 30.594  Millions
Enovis Corp  61.43 %$ 348.547  Millions$ 567.425  Millions
Resmed Inc   60.38 %$ 870.567  Millions$ 1,441.814  Millions
Angiodynamics Inc   59.37 %$ 48.040  Millions$ 80.915  Millions
National Vision Holdings Inc   58.85 %$ 300.471  Millions$ 510.533  Millions
Clearpoint Neuro Inc   58.46 %$ 7.059  Millions$ 12.075  Millions
Transmedics Group Inc   58.45 %$ 118.657  Millions$ 203.005  Millions
Nephros Inc   58.45 %$ 3.286  Millions$ 5.622  Millions
Envista Holdings Corporation  57.93 %$ 400.600  Millions$ 691.500  Millions
Infusystem Holdings Inc  57.80 %$ 21.727  Millions$ 37.589  Millions
Lensar Inc   57.77 %$ 8.164  Millions$ 14.131  Millions
Beta Bionics Inc   57.26 %$ 20.331  Millions$ 35.505  Millions
Hyperfine Inc   56.74 %$ 3.382  Millions$ 5.960  Millions
Tandem Diabetes Care Inc   56.55 %$ 160.422  Millions$ 283.690  Millions
Conmed Corporation  56.37 %$ 189.148  Millions$ 335.557  Millions
Solventum Corporation  54.49 %$ 1,062.000  Millions$ 1,949.000  Millions
Intelligent Bio Solutions Inc   54.46 %$ 0.758  Millions$ 1.392  Millions
Warby Parker Inc   54.41 %$ 133.171  Millions$ 244.735  Millions
Dentsply Sirona Inc   52.99 %$ 443.000  Millions$ 836.000  Millions
Neuronetics Inc   52.28 %$ 21.990  Millions$ 42.062  Millions
Pulse Biosciences Inc   51.65 %$ 0.204  Millions$ 0.395  Millions
Edap Tms Sa  51.40 %$ 5.052  Millions$ 9.828  Millions
Integra Lifesciences Holdings Corp  51.04 %$ 209.866  Millions$ 411.182  Millions
Capsovision Inc   49.44 %$ 1.764  Millions$ 3.568  Millions
Medinotec Inc   48.74 %$ 1.560  Millions$ 3.201  Millions
Merit Medical Systems Inc  48.20 %$ 200.631  Millions$ 416.244  Millions
Msa Safety Inc  45.53 %$ 244.231  Millions$ 536.430  Millions
Orasure Technologies Inc  45.20 %$ 13.969  Millions$ 30.907  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.